4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Xlife Sciences AG (XLS) operates in the Biotechnology industry and is headquartered in Zurich, Switzerland with about 20 employees. Its market capitalization is roughly CHF 50 million. In the fiscal year ended 2025-12-31, XLS reported CHF 0M in revenue and (CHF 22M) in net income.
Xlife Sciences AG focuses on the development and commercialization of research projects in the life sciences sector.
Interactive charts & full statements → Open the XLS valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CHF 0M | CHF 1M | CHF 1M | CHF 1M | — |
| Gross Profit | CHF 0M | CHF 0M | CHF 0M | CHF 0M | — |
| Operating Income (EBIT) | (CHF 32M) | (CHF 19M) | (CHF 20M) | (CHF 21M) | — |
| Net Income | (CHF 22M) | CHF 34M | CHF 15M | CHF 14M | — |
CHF; CHFM / CHFB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CHF 517M | CHF 540M | CHF 512M | CHF 490M | — |
| Total Liabilities | CHF 145M | CHF 144M | CHF 147M | CHF 152M | — |
CHF; CHFM / CHFB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive XLS viewer.
About TickerBase · Data methodology & sources · Privacy · Terms